Further research will now be required to determine whether ERO1α also impacts on other pathways such as PI3K-AktmTOR signalling which are frequently activated in pancreatic cancer and known to modulate cell proliferation, protein production, genomic stability, cellular metabolism, and metastatic potential. The gene discussed is ERO1A; the disease is pancreatic neoplasm.